Poland· PL-100025215
Fraxiparine
A nadroparin product containing nadroparinum calcicum, registered in Poland by Viatris Healthcare Sp. z o.o.. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Nadroparin is registered in 8 of 19 countries.
Countries holding a registration under ATC B01AB06 (nadroparin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Nadroparin · ATC B01AB06
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Nadroparinum calcicum
- Manufacturer
- Viatris Healthcare Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- B01AB06
- ATC class
- Nadroparin
- Defined daily dose
- 2.85 TSD, E
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
1 priced- gtin05909990075713
- gtin0590999007572010 amp.-strz.po 0,6 mlPLN 149.44
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nadroparin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsFraxiparine 2.850 IE/ 0,3 ml oplossing voor injectieMedcor Pharmaceuticals B.V.
- ItalySELEDIE*2 siringhe SC 11.400 UI 0,6 mlVIATRIS ITALIA Srl
- SwitzerlandFraxiforte 0.6 ml
- FranceFRAXIPARINE 1 900 U.I. Axa/0,2 ml, solution injectable (S.C.) en seringue pré-remplieVIATRIS SANTE
- SpainFRAXIPARINA 0,3 ml SOLUCION INYECTABLEAspen Pharma Trading Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/030ebb5c-04ce-4ad9-ac0a-51d65db91ba2 GET /v1/drugs/030ebb5c-04ce-4ad9-ac0a-51d65db91ba2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "5700 j.m.a.Xa/0,6 ml",
"packaging": "05909990075713 ¦ Rp ¦ 4063\n2 amp.-strzyk. 0,6 ml\n05909990075720 ¦ Rp ¦ 4064\n10 amp.-strzyk. 0,6 ml\nRp ¦ Skasowane ¦ 4065\n1 s-amp. 0,6 ml",
"substance": "Nadroparinum calcicum 5700 j.m./0,6 ml",
"common_name": "Nadroparinum calcicum",
"pl_product_id": "100025215",
"pozwolenie_nr": "00757",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about nadroparin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.